Notice - Updated Screening Criteria for Generic Drug Submissions

Notice - Updated Screening Criteria for Generic Drug Submissions The updated screening criteria for Abbreviated New Drug Submissions (ANDS) and their supplements (SANDS) will help assess the completeness of the drug submission and identify significant deficiencies prior to the review process. 2023-09-03 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetynoticereview processupdated screening criteriageneric drug submissionsabbreviated new drug-submissionsANDSsupplementsSANDScompleteness of drug-submissionsignificant deficiencies Notice - Updated Screening Criteria for Generic Drug SubmissionsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/forms/notice-updated-screening-criteria-generic-drug-submissions.html Notice - Updated Screening Criteria for Generic Drug SubmissionsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/formulaires/avis-mise-jour-criteres-examen-preliminaire-presentations-medicaments-generiques.html

The updated screening criteria for Abbreviated New Drug Submissions (ANDS) and their supplements (SANDS) will help assess the completeness of the drug submission and identify significant deficiencies prior to the review process.

Data and Resources

Similar records